WNT signalling in prostate cancer
V Murillo-Garzón, R Kypta - Nature Reviews Urology, 2017 - nature.com
Genome sequencing and gene expression analyses of prostate tumours have highlighted
the potential importance of genetic and epigenetic changes observed in WNT signalling …
the potential importance of genetic and epigenetic changes observed in WNT signalling …
[HTML][HTML] Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis
K van Loon, EJM Huijbers, AW Griffioen - Cancer and Metastasis Reviews, 2021 - Springer
Secreted frizzled-related proteins (SFRP) are glycoproteins containing a so-called frizzled-
like cysteine-rich domain. This domain enables them to bind to Wnt ligands or frizzled (FzD) …
like cysteine-rich domain. This domain enables them to bind to Wnt ligands or frizzled (FzD) …
Secreted frizzled related proteins: Implications in cancers
R Surana, S Sikka, W Cai, EM Shin, SR Warrier… - … et Biophysica Acta (BBA …, 2014 - Elsevier
The Wnt (wingless-type) signaling pathway plays an important role in embryonic
development, tissue homeostasis, and tumor progression becaluse of its effect on cell …
development, tissue homeostasis, and tumor progression becaluse of its effect on cell …
Differential DNA methylation in peripheral blood mononuclear cells in adolescents exposed to significant early but not later childhood adversity
Internationally adopted adolescents who are adopted as young children from conditions of
poverty and deprivation have poorer physical and mental health outcomes than do …
poverty and deprivation have poorer physical and mental health outcomes than do …
[HTML][HTML] SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment
Y Sun, D Zhu, F Chen, M Qian, H Wei, W Chen, J Xu - Oncogene, 2016 - nature.com
Most tumors initially respond to cytotoxic treatments, but acquired resistance often follows.
The tumor microenvironment (TME) is a major barrier to clinical success by compromising …
The tumor microenvironment (TME) is a major barrier to clinical success by compromising …
Wnt/Beta-catenin signaling and prostate cancer therapy resistance
Metastatic or locally advanced prostate cancer (PCa) is typically treated with androgen
deprivation therapy (ADT). Initially, PCa responds to the treatment and regresses. However …
deprivation therapy (ADT). Initially, PCa responds to the treatment and regresses. However …
[HTML][HTML] Wnt signaling in castration-resistant prostate cancer: implications for therapy
NN Yokoyama, S Shao, BH Hoang… - American journal of …, 2014 - ncbi.nlm.nih.gov
Increasing evidence has indicated that Wnt signaling plays complex roles in castration
resistant prostate cancer (CRPC). Although not all data were consistent, β-catenin nuclear …
resistant prostate cancer (CRPC). Although not all data were consistent, β-catenin nuclear …
[HTML][HTML] Exploring the Wnt pathway as a therapeutic target for prostate cancer
S Koushyar, VS Meniel, TJ Phesse, HB Pearson - Biomolecules, 2022 - mdpi.com
Aberrant activation of the Wnt pathway is emerging as a frequent event during prostate
cancer that can facilitate tumor formation, progression, and therapeutic resistance. Recent …
cancer that can facilitate tumor formation, progression, and therapeutic resistance. Recent …
[HTML][HTML] Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta‑analysis
J Yu, Y Xie, M Li, F Zhou, Z Zhong, Y Liu… - Oncology …, 2019 - spandidos-publications.com
Abnormal methylation of secreted frizzled‑related proteins (SFRPs) has been observed in
various human cancer types. The loss of SFRP gene expression induces the activation of …
various human cancer types. The loss of SFRP gene expression induces the activation of …
Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism
Osteosarcoma (OS), the most common primary bone tumor, is highly metastatic with high
chemotherapeutic resistance and poor survival rates. Using induced pluripotent stem cells …
chemotherapeutic resistance and poor survival rates. Using induced pluripotent stem cells …